Muted Listing: Sagility India Makes Tepid Debut On Exchanges At 3.5% Premium From IPO Price; BUY?

Sagility India Limited made a lukewarm debut on the NSE and BSE, listing at Rs 31.06 on November 12, a modest 3.53% premium over its issue price of Rs 30. The initial public offering (IPO), which aimed to raise Rs 2,106.60 crore, was open for subscription from November 5 to November 7 with a price band set between Rs 28 and Rs 30 per share.

IPO Demand

Sagility India's IPO attracted significant demand from various investor segments, closing with an overall subscription of 3.2 times. The IPO received bids for 123.99 crore shares against the 38.7 crore shares on offer, showcasing strong market interest. The retail investor category was oversubscribed by 4.16 times, while the non-institutional investor (NII) category saw a subscription level of 1.93 times. Notably, the qualified institutional buyers (QIB) segment was fully subscribed at 3.52 times. Additionally, the employee quota received 3.75 times bids.

Structure of the Sagility IPO

The Sagility IPO was an entirely offer-for-sale (OFS) issue, involving 70.22 crore shares, which means there was no fresh capital infusion for the company itself. Post-IPO, the promoter shareholding has decreased to 82.5%, enabling greater public participation in Sagility's ownership. The company raised Rs 945.40 crore from anchor investors on November 4, underscoring strong pre-listing support. The minimum lot size was set at 500 shares, making the entry threshold Rs 15,000 for retail investors. Employees of Sagility were offered a discounted rate of Rs 28 per share, with up to 1.9 million shares reserved specifically for them as part of the company's employee engagement strategy.

The primary objective of the listing is not capital generation for business expansion, as Sagility will not receive any proceeds from this sale. Instead, the offering aims to achieve the advantages associated with listing on public exchanges and to facilitate liquidity for the promoter group through the offer-for-sale mechanism.

About Sagility India

Founded as Berkmeer India Private Limited, Sagility India has since evolved into a player in healthcare solutions, catering primarily to Payers and Providers in the US healthcare market. The company's service suite is structured to address key operational needs within the healthcare ecosystem. For Payers (mainly US-based health insurers), Sagility delivers a range of services, including claims administration, clinical services, payment integrity, and clinical management, ensuring efficient operations and optimized reimbursement processes.

In addition, Sagility supports Providers, such as hospitals and physician practices, with revenue cycle management services that help streamline billing processes and ensure timely cost recovery. These services extend to Pharmacy Benefit Managers (PBMs), who handle prescription drug benefits for health plan members.

Financial Performance

Sagility India's financial track record indicates a healthy growth trajectory, with revenues and profits steadily increasing. For the fiscal year 2023-24, the company reported a 12.6% growth in revenue, reaching Rs 4,753 crore, up from Rs 4,218 crore in the previous fiscal year. Profit after tax (PAT) rose sharply by 59%, totalling Rs 228.2 crore in FY24, compared to Rs 143.5 crore in FY23. For the first quarter of FY25, Sagility posted revenues of Rs 1,223 crore alongside a net profit of Rs 22.2 crore.

Key Players

The Sagility IPO was managed by prominent book-running lead managers, including ICICI Securities Limited, IIFL Securities Ltd, Jefferies India Private Limited, and JP Morgan India Private Limited. Link Intime India Private Ltd served as the registrar for the IPO.